Bone Marrow Derived Mesenchymal Stromal Cells Harness Purinergenic Signaling to Tolerize Human Th1 Cells In Vivo

The use of bone marrow derived mesenchymal stromal cells (BMSC) in the treatment of alloimmune and autoimmune conditions has generated much interest, yet an understanding of the therapeutic mechanism remains elusive. We therefore explored immune modulation by a clinical-grade BMSC product in a model...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells
Main Authors: Amarnath, Shoba, Foley, Jason E., Farthing, Don E., Gress, Ronald E., Laurence, Arian, Eckhaus, Michael A., Métais, Jean-Yves, Rose, Jeremy J., Hakim, Frances T., Felizardo, Tania C., Cheng, Austin V., Robey, Pamela G., Stroncek, David E., Sabatino, Marianna, Battiwalla, Minoo, Ito, Sawa, Fowler, Daniel H., Barrett, Austin J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4376558/
https://ncbi.nlm.nih.gov/pubmed/25532725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/stem.1934
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados